Yes, Biodesix, Inc. executed a one-for-twenty reverse stock split of its common stock, which became officially effective in September 2025. This corporate action was overwhelmingly approved by the company's stockholders during its annual meeting to consolidate the number of issued and outstanding shares and boost the per-share trading value. The adjustment helped the enterprise maintain its compliance with the minimum bid price requirements necessary to remain listed on the Nasdaq Global Market.